oxfendazole has been researched along with Cancer of Ovary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Huang, L; Huang, S; Li, L; Li, Z; Ou, Y; Tang, W; Wen, C; Wu, S; Wu, Z; Xiang, Y; Ye, W; Zhong, S; Zhou, C | 1 |
1 other study(ies) available for oxfendazole and Cancer of Ovary
Article | Year |
---|---|
Oxfendazole Induces Apoptosis in Ovarian Cancer Cells by Activating JNK/MAPK Pathway and Inducing Reactive Oxygen Species Generation.
Topics: Anthelmintics; Apoptosis; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Ovarian Neoplasms; Reactive Oxygen Species | 2023 |